The PCR-invader method (structure-specific 5' nuclease-based method), a sensitive method for detecting EGFR gene mutations in lung cancer specimens; comparison with direct sequencing. (Q54388246)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The PCR-invader method (structure-specific 5' nuclease-based method), a sensitive method for detecting EGFR gene mutations in lung cancer specimens; comparison with direct sequencing.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21311943

The PCR-invader method (structure-specific 5' nuclease-based method), a sensitive method for detecting EGFR gene mutations in lung cancer specimens; comparison with direct sequencing. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21311943

author name string

Katsuhiko Naoki

1

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21311943

Kenzo Soejima

2

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21311943

Hiroaki Okamoto

3

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21311943

Junko Hamamoto

4

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21311943

Naoya Hida

5

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21311943

Ichiro Nakachi

6

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21311943

Hiroyuki Yasuda

7

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21311943

Sohei Nakayama

8

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21311943

Satoshi Yoda

9

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21311943

Ryosuke Satomi

10

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21311943

Shinnosuke Ikemura

11

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21311943

Hideki Terai

12

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21311943

Takashi Sato

13

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21311943

Koshiro Watanabe

14

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21311943

publication date

11 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21311943

International Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21311943

16

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21311943

4

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21311943

335-344

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21311943

https://scigraph.springernature.com/pub.10.1007/s10147-011-0187-5

0 references

Somatic mutations affect key pathways in lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0187-5

21 January 2018

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0187-5

21 January 2018

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0187-5

21 January 2018

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0187-5

21 January 2018

Screening for epidermal growth factor receptor mutations in lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0187-5

21 January 2018

An alternative method for screening EGFR mutation using RFLP in non-small cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0187-5

21 January 2018

Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting.

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0187-5

21 January 2018

The Invader assay for SNP genotyping

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0187-5

21 January 2018

Sensitive detection of DNA polymorphisms by the serial invasive signal amplification reaction

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0187-5

21 January 2018

Classification of hepatitis B virus genotypes by the PCR-Invader method with genotype-specific probes

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0187-5

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0187-5

21 January 2018

The combination of multiple receptor tyrosine kinase inhibitor and mammalian target of rapamycin inhibitor overcomes erlotinib resistance in lung cancer cell lines through c-Met inhibition.

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0187-5

21 January 2018

Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0187-5

21 January 2018

A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0187-5

21 January 2018

Gefitinib for non-small-cell lung cancer patients with epidermal growth factor receptor gene mutations screened by peptide nucleic acid-locked nucleic acid PCR clamp

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0187-5

21 January 2018

Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403).

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0187-5

21 January 2018

New approaches for genotyping paraffin wax embedded breast tissue from patients with cancer: the Iowa women's health study

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0187-5

21 January 2018

Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0187-5

21 January 2018

Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0187-5

21 January 2018

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0187-5

21 January 2018

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0187-5

21 January 2018

Prospective Validation for Prediction of Gefitinib Sensitivity by Epidermal Growth Factor Receptor Gene Mutation in Patients with Non-Small Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0187-5

21 January 2018

Missense mutations of the BRAF gene in human lung adenocarcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21311943

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective validation for prediction of gefitinib sensitivity by epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21311943

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bronchoscopic microsampling is a useful complementary diagnostic tool for detecting lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21311943

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes

1 reference

https://pubmed.ncbi.nlm.nih.gov/21311943

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High sensitivity detection of epidermal growth factor receptor mutations in the pleural effusion of non-small cell lung cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21311943

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor mutation detection using high-resolution melting analysis predicts outcomes in patients with advanced non small cell lung cancer treated with gefitinib

1 reference

https://pubmed.ncbi.nlm.nih.gov/21311943

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II prospective study of the efficacy of gefitinib for the treatment of stage III/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21311943

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid quantification of the heteroplasmy of mutant mitochondrial DNAs in Leber's hereditary optic neuropathy using the Invader technology

1 reference

https://pubmed.ncbi.nlm.nih.gov/21311943

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp

1 reference

https://pubmed.ncbi.nlm.nih.gov/21311943

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10147-011-0187-5

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21311943

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21311943

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54388246&oldid=1408301507"